This is where GLP-1 receptor agonists (Semaglutide and Tirzepatide) and NAD+ therapy can play a vital role in breaking through weight loss resistance
We have a population that has learned correctly that pharmaceutical companies have lied, that institutions have failed them, and that financial incentives distort medical recommendations
The most meaningful improvements come when treatment addresses root causes oxidative stress, nutrition, liver health, and lifestyle rather than surface symptoms alone
et al., 2020), E ACT or F ACT (Namkung et al., 2011) which would increase the activity of TMEM16A, subsequently increasing chloride and bicarbonate transport to propel water into mucus, or decrease the activity of ENaC, reducing sodium transport intracellularly and increasing water retained in mucus, could be very beneficial but are still far from public use (Livraghi-Butrico et al., 2013